Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marylin M. Li"'
Autor:
Erfan Aref-Eshghi, Marylin M. Li
Publikováno v:
Advances in Molecular Pathology. 5:9-27
Autor:
David S. Hong, Funda Meric-Bernstam, Razelle Kurzrock, Ravi Salgia, Raja Luthra, Sinchita Roy-Chowdhuri, Marylin M. Li, Vijaykumar Holla, Apostolia M. Tsimberidou, Aung Naing, Ralph G. Zinner, Jennifer J. Wheler, Siqing Fu, Filip Janku, Kenneth Hess, Gerald S. Falchook, Debora De Melo Gagliato, Chad Tang, Denis L.F. Jardim
Table S1 - Histologies and tumor grade by site according to MET amplification status. Table S2- Type of BRAF mutations by tumor site. Table S3 - List of phase I trials included as best trials for MET amplified patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367ab0e7239529ff75c0d1518e716bdf
https://doi.org/10.1158/1078-0432.22459130
https://doi.org/10.1158/1078-0432.22459130
Autor:
David S. Hong, Funda Meric-Bernstam, Razelle Kurzrock, Ravi Salgia, Raja Luthra, Sinchita Roy-Chowdhuri, Marylin M. Li, Vijaykumar Holla, Apostolia M. Tsimberidou, Aung Naing, Ralph G. Zinner, Jennifer J. Wheler, Siqing Fu, Filip Janku, Kenneth Hess, Gerald S. Falchook, Debora De Melo Gagliato, Chad Tang, Denis L.F. Jardim
Purpose: This study aimed to assess MET amplification among different cancers, association with clinical factors and genetic aberrations and targeted therapy response modifications.Experimental Design: From May 2010 to November 2012, samples from pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5bde600b9f595ddb35005078b723039
https://doi.org/10.1158/1078-0432.c.6524138.v1
https://doi.org/10.1158/1078-0432.c.6524138.v1
Autor:
Peter Horak, Malachi Griffith, Arpad M. Danos, Beth A. Pitel, Subha Madhavan, Xuelu Liu, Cynthia Chow, Heather Williams, Leigh Carmody, Lisa Barrow-Laing, Damian Rieke, Simon Kreutzfeldt, Albrecht Stenzinger, David Tamborero, Manuela Benary, Padma Sheila Rajagopal, Cristiane M. Ida, Harry Lesmana, Laveniya Satgunaseelan, Jason D. Merker, Michael Y. Tolstorukov, Paulo Vidal Campregher, Jeremy L. Warner, Shruti Rao, Maya Natesan, Haolin Shen, Jeffrey Venstrom, Somak Roy, Kayoko Tao, Rashmi Kanagal-Shamanna, Xinjie Xu, Deborah I. Ritter, Kym Pagel, Kilannin Krysiak, Adrian Dubuc, Yassmine M. Akkari, Xuan Shirley Li, Jennifer Lee, Ian King, Gordana Raca, Alex H. Wagner, Marylin M. Li, Sharon E. Plon, Shashikant Kulkarni, Obi L. Griffith, Debyani Chakravarty, Dmitriy Sonkin
Publikováno v:
Genet Med
PURPOSE: Several professional societies have published guidelines for the clinical interpretation of somatic variants, which specifically address diagnostic, prognostic, and therapeutic implications. While these guidelines for the clinical interpreta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149b200477e66e98e0ab2750c5171fa2
https://europepmc.org/articles/PMC9081216/
https://europepmc.org/articles/PMC9081216/
Autor:
Jennifer J. Wheler, Sinchita Roy-Chowdhuri, Marylin M. Li, Vijay Kumar Holla, Denis Leonardo Fontes Jardim, Filip Janku, Gerald S. Falchook, Raja Luthra, Siqing Fu, Apostolia Maria Tsimberidou, Razelle Kurzrock, Aung Naing, Funda Meric-Bernstam, Debora de Melo Gagliato, David S. Hong, Kenneth R. Hess, Chad Tang, Ravi Salgia, Ralph Zinner
Publikováno v:
Clinical Cancer Research. 20:6336-6345
Purpose: This study aimed to assess MET amplification among different cancers, association with clinical factors and genetic aberrations and targeted therapy response modifications. Experimental Design: From May 2010 to November 2012, samples from pa